Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004627
Filing Date
2018-05-10
Accepted
2018-05-10 16:02:27
Documents
69
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eglt-20180331x10q.htm 10-Q 1616399
2 EX-10.1 eglt-20180331ex1010128f0.htm EX-10.1 143782
3 EX-31.1 eglt-20180331ex31198f016.htm EX-31.1 16605
4 EX-31.2 eglt-20180331ex312d2752e.htm EX-31.2 16804
5 EX-32.1 eglt-20180331ex32106dadc.htm EX-32.1 8852
6 EX-32.2 eglt-20180331ex3228c9d14.htm EX-32.2 8372
  Complete submission text file 0001558370-18-004627.txt   8641867

Data Files

Seq Description Document Type Size
7 EX-101.INS eglt-20180331.xml EX-101.INS 2027186
8 EX-101.SCH eglt-20180331.xsd EX-101.SCH 64800
9 EX-101.CAL eglt-20180331_cal.xml EX-101.CAL 52696
10 EX-101.DEF eglt-20180331_def.xml EX-101.DEF 294692
11 EX-101.LAB eglt-20180331_lab.xml EX-101.LAB 580659
12 EX-101.PRE eglt-20180331_pre.xml EX-101.PRE 435536
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Egalet Corp (Filer) CIK: 0001586105 (see all company filings)

EIN.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36295 | Film No.: 18822387
SIC: 2834 Pharmaceutical Preparations